{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:24:05Z","timestamp":1769027045763,"version":"3.49.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>\n                    Gastrointestinal (GI) metastases from breast cancer are uncommon, with rectal involvement being particularly rare. Here, we present a case of a 55-year-old female with a history of bilateral breast cancer who developed rectal metastasis seven years after initial diagnosis. The patient was initially diagnosed in 2017 with left breast invasive ductal carcinoma (IDC) and right breast ductal carcinoma\n                    <jats:italic>in situ<\/jats:italic>\n                    (DCIS). Despite receiving comprehensive treatment, including modified radical mastectomy, chemotherapy, radiotherapy, and endocrine therapy, she experienced multiple metastases involving the bones, lymph nodes, and pleura. In 2024, she presented with new bowel symptoms, and colonoscopy revealed rectal wall thickening with stenosis. Biopsy confirmed metastatic breast cancer with immunohistochemistry showing GATA3(+), CDX2(-), and loss of hormone receptor expression compared to the primary tumor. This case underscores the importance of considering gastrointestinal metastasis in breast cancer patients with bowel symptoms, even years after initial treatment. We also review the literature regarding the literature on the diagnosis, treatment, and prognosis of breast cancer rectal metastasis.\n                  <\/jats:p>","DOI":"10.3389\/fonc.2026.1597103","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:38:13Z","timestamp":1768973893000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Rectal metastasis in a patient with long-term breast cancer: a rare case report with literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaohong","family":"Lyu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2005.03.030","article-title":"Breast cancer: presentation and intervention in women with gastrointestinal metastasis and carcinomatosis","volume":"12","author":"McLemore","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v12.i5.382","article-title":"Intestinal metastasis from breast cancer: Presentation, treatment and survival from a systematic literature review","volume":"12","author":"Bolzacchini","year":"2021","journal-title":"World J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/bjc.1984.135","article-title":"A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast","volume":"50","author":"Harris","year":"1984","journal-title":"Br J Cancer"},{"key":"B5","article-title":"Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast","volume":"114","author":"Borst","year":"1993","journal-title":"Surgery"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10040108","article-title":"Immunohistochemistry for diagnosis of metastatic carcinomas of unknown primary site","volume":"10","author":"Selves","year":"2018","journal-title":"Cancers (Basel)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"439023","DOI":"10.1155\/2012\/439023","article-title":"Metastatic breast cancer to the gastrointestinal tract: report of five cases and review of the literature","volume":"2012","author":"Ambroggi","year":"2012","journal-title":"Int J Breast Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"997","DOI":"10.5152\/tjg.2019.18649","article-title":"Report of two cases and a systematic review of breast cancer with gastrointestinal metastasis","volume":"30","author":"Zhong","year":"2019","journal-title":"Turk J Gastroenterol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i38.6219","article-title":"Metastatic breast cancer to the gastrointestinal tract: a case series and review of the literature","volume":"12","author":"Nazareno","year":"2006","journal-title":"World J Gastroenterol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1477-7819-5-75","article-title":"Breast cancer metastasis to the stomach may mimic primary gastric cancer: report of two cases and review of literature","volume":"5","author":"Jones","year":"2007","journal-title":"World J Surg Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/bctt.S79506","article-title":"Gastric and colon metastasis from breast cancer: case report, review of the literature, and possible underlying mechanisms","volume":"9","author":"Villa Guzm\u00e1n","year":"2017","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.14218\/OnA.2024.00001","article-title":"Breast cancer metastasizing to the lower gastrointestinal tract (the small bowel and colon): A case presentation and comprehensive review of the literature","volume":"2","author":"Da Cunha","year":"2024","journal-title":"Oncol Adv"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800731","article-title":"Breast-specific expression of MGB1\/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers","volume":"20","author":"Sasaki","year":"2007","journal-title":"Mod Pathol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20001201)89:11<2214::AID-CNCR9>3.0.CO;2-D","article-title":"Clinical presentation, endoscopic features, and treatment of gastric metastases from breast carcinoma","volume":"89","author":"Taal","year":"2000","journal-title":"Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3892\/ol.2023.13972","article-title":"Breast cancer metastases to the thyroid and stomach: A case report","volume":"26","author":"Bai","year":"2023","journal-title":"Oncol Lett"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1573163","article-title":"Breast cancer metastases to the stomach with endoscopic submucosal dissection: a case report and literature study","volume":"15","author":"Zhao","year":"2025","journal-title":"Front Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13058-021-01462-3","article-title":"ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer","volume":"23","author":"Brett","year":"2021","journal-title":"Breast Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-017-0306-5","article-title":"The impact of ESR1 mutations on the treatment of metastatic breast cancer","volume":"9","author":"Pejerrey","year":"2018","journal-title":"Horm Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15072015","article-title":"Filling the gap after CDK4\/6 inhibitors: novel endocrine and biologic treatment options for metastatic hormone receptor positive breast cancer","volume":"15","author":"Mittal","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.16732","article-title":"Mechanism of CDK4\/6 inhibitor resistance in hormone receptor-positive breast cancer and alternative treatment strategies","volume":"43","author":"Chang","year":"2023","journal-title":"Anticancer Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-1390","article-title":"The genomic landscape of intrinsic and acquired resistance to cyclin-dependent kinase 4\/6 inhibitors in patients with hormone receptor-positive metastatic breast cancer","volume":"10","author":"Wander","year":"2020","journal-title":"Cancer Discov"},{"key":"B23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.21037\/tbcr-25-11","article-title":"Precision therapy in metastatic breast cancer: the current landscape of molecular alteration-based therapies","volume":"6","author":"Abdullah","year":"2025","journal-title":"Transl Breast Cancer Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41523-024-00617-7","article-title":"CDK4\/6i-treated HR+\/HER2- breast cancer tumors show higher ESR1 mutation prevalence and more altered genomic landscape","volume":"10","author":"Chaudhary","year":"2024","journal-title":"NPJ Breast Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/s41467-025-55914-x","article-title":"Real-world clinical multi-omics analyses reveal bifurcation of ER-independent and ER-dependent drug resistance to CDK4\/6 inhibitors","volume":"16","author":"Kan","year":"2025","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1148792","article-title":"CDK4\/6 inhibitor resistance in estrogen receptor positive breast cancer, a 2023 perspective","volume":"11","author":"Zhou","year":"2023","journal-title":"Front Cell Dev Biol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1597103\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:38:17Z","timestamp":1768973897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1597103\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":26,"alternative-id":["10.3389\/fonc.2026.1597103"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1597103","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"article-number":"1597103"}}